| 英文名称 | 中文名称 | CAS | MF |
|
paromomycin
|
小串菌素
|
7542-37-2
|
C23H45N5O14
|
|
PARP (Cleaved) Monoclonal Antibody
|
PARP (裂解) 单克隆抗体
|
|
|
|
PARP Cleavage Detection Kit
|
|
|
|
|
PARP Cleavage Site (214/215) (Poly ADP-Ribose Polymerase) (Biotin)
|
PARP切割位点(214/215)(多聚ADP核糖聚合酶)(生物素)
|
|
|
|
PARP, Cleaved (Poly ADP-Ribose Polymerase)
|
|
|
|
|
PARP Cleavage Site (214/215) (Poly ADP-Ribose Polymerase)
|
PARP切割位点(214/215)(多聚ADP核糖聚合酶)
|
|
|
|
PAROMOMYCIN SULFATE USP(CRM STANDARD)
|
|
|
|
|
PAROMOMYCIN SULFATE WHO(CRM STANDARD)
|
|
|
|
|
PAROMOMYCIN SULFATE
|
硫酸巴龙霉素
|
1263-89-4
|
C23H47N5O18S
|
|
PAROMOMYCIN, [3H]-
|
|
|
C23H44N5O14T
|
|
PARP (Cleaved) Polyclonal Ab
|
|
|
|
|
paromamine
|
4-O-(2-氨基-2-脱氧-ALPHA-D-吡喃葡萄糖基)-2-脱氧-D-链霉胺
|
534-47-4
|
C12H25N3O7
|
|
paromomycin phosphotransferase
|
|
|
|
|
PARP Cleavage Site (214/215) (Poly ADP-Ribose Polymerase) (FITC)
|
PARP切割位点(214/215)(多聚ADP核糖聚合酶)(FITC)
|
|
|
|
PARP Cellular ELISA
|
|
|
|
|
PARP Enzyme High Specific Activity (500 UL)
|
PARP酶,高比放射性(500UL)
|
|
|
|
PARP Enzyme (250 uL) (250 UL)
|
PARP酶(250UL)(250UL)
|
|
|
|
PARP Enzyme (50 uL) (50 UL)
|
PARP酶(50UL)(50UL)
|
|
|
|
PARP Enzyme High Specific Activity (100 UL)
|
PARP酶,高比放射性(100UL)
|
|
|
|
PARORETINE
|
|
|
|
|
PARP Histochemistry Kit
|
|
|
|
|
PARP(IHC dilution: Ready-to-use)
|
即用型
|
|
|
|
PARP(IHC dilution: 1:100)
|
1:100稀释
|
|
|
|
PARP Inhibitor Set
|
|
|
|
|
PBI-429 [ETHYNYL-UL-14C] METHYL 8'-ACETELENE ABA
|
|
|
|
|
parotid secretory protein
|
|
|
|
|
Parotin
|
|
1392-81-0
|
|
|
P-(B IETHYLAMINO)ETHOXYDIPHENYL KETONE
|
|
|
|
|
parotid salivary histidine-rich polypeptide
|
|
117233-32-6
|
C142H204N52O35
|
|
Pasetocin-13C2,15N
|
Pasetocin-13C2,15N
|
1357002-99-3
|
C16H19N3O5S
|
|
PARP (LP96-22) Antibody
|
|
|
|
|
PARP (LP96-24) Antibody
|
|
|
|
|
PARP Monoclonal Ab (clone c-2-10)
|
PARP单克隆抗体
|
|
|
|
PAROXETINE RELATED COMPOUND C (15 MG) ((+)-TRANS-PAROXETINE HYDROCHLORIDE)
|
帕罗西汀相关物质C
|
130855-30-0
|
C19H21ClFNO3
|
|
Paroxetine SysteM Suitability Mixture A
|
帕罗西汀系统适用混合物A
|
|
|
|
Paroxol Methanesulfonate
|
Paroxol Methanesulfonate
|
608521-21-7
|
C14H20FNO3S
|
|
Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride)
|
Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride)
|
|
|
|
Paroxetine Related Compound B (15 mg) (Trans-4-phenyl-3-[(3,4-methylenedioxy)phenoxymethyl]piperidine hydrochloride)
|
|
|
|
|
Paroxetine Related Compound E Mixture (25 mg) (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix)
|
Paroxetine Related Compound E Mixture (25 mg) (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix)
|
|
|
|
paroxetine Mesylate
|
甲磺酸帕罗西汀
|
217797-14-3
|
C20H24FNO6S
|
|
Paroxetine-d2
|
|
|
|
|
PAROXETINEMETABOLITE
|
|
|
|
|
PBIEX(TM)-3 DNA
|
|
|
|
|
Paroxetine maleate
|
马来酸帕罗西汀
|
64006-44-6
|
C23H24FNO7
|
|
ParoxetineHcl,Seroxat
|
|
|
|
|
pBiEx-2 DNA *
|
|
|
|
|
pBiEx-1 DNA *
|
|
|
|
|
PAROXETINE RELATED COMPOUND D(-)-CIS-PAROXETINE HCL USP(CRM STANDARD)
|
|
|
|
|
PAROXETINE IMPURITY C(3S,4R)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-ETHOXYPHENYL)-PIPERIDINE EPY(CRM STANDARD)
|
|
|
|
|
PAROXETINE HCL USP STANDARD
|
|
|
|
|
PAROXETINE RELATED COMPOUND BTRANS-4-PHENYL-3-([(3,4-METHYLENEDIOXY)PHENOXY]METHYLPIPERIDINE ACETATE USP(CRM STANDARD)
|
|
|
|
|
paroxctine
|
|
|
|
|
PAROXETINE RELATED COMPOUND ATRANS-4-(P-METHOXYPHENYL)-3-[(3,4-METHYLENEDIOXY)PHENOXY]METHYLPIPERIDINE HCL USP(CRM STANDARD)
|
|
|
|
|
PAROXETINE RELATED COMPOUND C(+)-TRANS-PAROXETINE HCL USP(CRM STANDARD)
|
|
|
|
|
PAROXETINE HYDROCHLORIDE HEMIHYDRATE EPY(CRM STANDARD)
|
|
|
|
|
PAROXETINE IMPURITY D(3R,4S)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE ((+)-TRANS-PAROXETINE) STORE LONG TERM AT -20°C COOL PACK EPY(CRM STANDARD)
|
|
|
|
|
PAROXETINE-D6 MALEATE
|
PAROXETINE-D6 MALEATE SOLUTION
|
1435728-64-5
|
C23H24FNO7
|
|
PAROXETINE IMPURITY A(3S,4R)-3-[[1,3-BENZODIOXOL-5-YLOXY]METHYL]-4-PHENYLPIPERIDINE (DESFLUOROPAROXETINE) EPY(CRM STANDARD)
|
|
|
|
|
PAROXETINE-D4 HCL
|
盐酸帕罗西汀
|
110429-35-1
|
C19H23ClFNO4
|
|
PBIEX(TM)-2 DNA
|
|
|
|
|
pBiEx-3 DNA *
|
|
|
|
|
Paroxetine Intermediate(-)
|
|
|
|
|
Paroxetine
|
帕罗西汀
|
61869-08-7
|
C19H20FNO3
|
|
Paroxetine HCL EP
|
帕罗西汀盐酸盐
|
|
|
|
Paroxetine.1/2 H2O.HCL
|
帕罗西丁
|
|
|
|
PAROXETINE
|
|
|
C19H20FNO3
|
|
4-(4-Fluorophenyl)-3-(4-methoxy-3-hydroxyphenoxymethyl)piperidine
|
4-(4-氟苯基)-3-(4-甲氧基-3-羟基苯氧基甲基)哌啶
|
112058-89-6
|
C19H22FNO3
|
|
PAROXETIVE
|
|
|
|
|
PAROXETINE, [PHENYL-6'-3H]-
|
|
|
C19H19FNO3T
|
|
PBIEX(TM)-1 DNA
|
|
|
|
|
Paroxetine hydrochloride
|
帕罗西汀盐酸盐
|
78246-49-8
|
C19H21ClFNO3
|
|
paroxetine receptor
|
|
|
|
|
PARP Polyclonal Antibody
|
PARP多克隆抗体
|
|
|
|
PARP (Poly ADP-Ribose Polymerase) (BSA & Azide Free)
|
PARP(多聚ADP核糖聚合酶)(BSA&无叠氮化合物)
|
|
|
|
PARP protein
|
|
|
|
|
par2 protein, fungal
|
|
|
|
|
PAR-1 protein
|
|
|
|
|
Pbh1 protein
|
|
|
|
|
PAR-3 protein
|
|
|
|
|
par1 protein, fungal
|
|
|
|
|
PAR-6 protein
|
|
|
|
|
par-2 protein
|
|
|
|
|
par-4 protein
|
|
|
|
|
PAR 2 protein
|
|
148294-53-5
|
|
|
PAR(R)
|
|
|
|
|
Pashanbheda
|
|
|
|
|
ParrafinWax
|
|
|
|
|
PAS-6-7 glycoprotein
|
|
|
|
|
PASI 535
|
|
|
|
|
PASI
|
|
|
|
|
PBI-G TET VECTOR
|
|
|
|
|
4-Aminophenylarsonic acid
|
阿散酸
|
98-50-0
|
C6H8AsNO3
|
|
parsalmide
|
帕沙米特
|
30653-83-9
|
C14H18N2O2
|
|
PARQUETLAYERS
|
|
|
|
|
PAR-1-selective peptide
|
THR-PHE-LEU-LEU-ARG-ASN
|
|
|
|
Melarsen Oxide
|
对偶砷苯基密胺
|
21840-08-4
|
C9H9AsN6O
|
|
P-ARSENOSOBENZOICACIDSODIUMSALT
|
|
|
|
|
PARROT
|
|
|
|
|
ParR protein
|
|
|
|
|
Parsley, ext.
|
欧芹提取物
|
84012-33-9
|
|